H15.043 Scleritis with corneal involvement, bilateral

Name of the Condition

• Scleritis with corneal involvement, bilateral
• Medical Term: Scleritis with corneal involvement, bilateral
• ICD Code: H15.043

Summary

Scleritis with corneal involvement, bilateral, is an inflammatory condition affecting the sclera (the tough, white outer layer of both eyeballs) and extending to the cornea. This can cause significant eye pain and may lead to vision-threatening complications if not managed appropriately. The condition often requires prompt evaluation and treatment to prevent long-term damage.

Causes

Scleritis with corneal involvement, bilateral, may result from autoimmune disorders, infections, or systemic inflammatory diseases. Autoimmune conditions such as rheumatoid arthritis, lupus, or granulomatosis with polyangiitis are common underlying causes. Infections like herpes zoster or syphilis, as well as trauma or surgery, can also trigger scleral inflammation that involves the cornea. In some cases, the cause remains idiopathic.

Risk Factors

• Autoimmune diseases (e.g., rheumatoid arthritis, lupus)
• Systemic inflammatory conditions (e.g., vasculitis)
• History of eye trauma or surgery
• Age-related changes in scleral tissue
• Exposure to infectious agents

Symptoms

• Severe, deep eye pain, often described as aching or throbbing
• Redness, typically localized to the sclera
• Blurred vision or reduced visual acuity
• Sensitivity to light (photophobia)
• Tearing or discharge
• Swelling of the eyelids

Diagnosis

Diagnosis involves a comprehensive eye examination, including slit-lamp biomicroscopy to assess scleral and corneal inflammation. Visual acuity testing, intraocular pressure measurement, and imaging (e.g., ultrasound or optical coherence tomography) may be used to evaluate the extent of involvement. Laboratory tests, such as blood work or infectious disease screening, help identify underlying causes. A thorough medical history is essential to correlate symptoms with potential systemic conditions.

Treatment Options

Treatment focuses on reducing inflammation and addressing underlying causes. Topical or systemic corticosteroids are commonly used to control inflammation. Immunosuppressive agents may be necessary for autoimmune-related cases. Antibiotics or antiviral medications are prescribed if an infection is present. Pain management and lubricating eye drops may also be recommended to alleviate discomfort and protect the cornea.

Prognosis and Follow-Up

Prognosis depends on the severity of inflammation and timely treatment. Early intervention can prevent vision loss, but recurrent or severe cases may lead to complications. Regular follow-up appointments are crucial to monitor inflammation, adjust treatment, and assess visual function. Long-term management may be required for chronic or recurrent disease.

Complications

• Vision loss or permanent visual impairment
• Corneal thinning or perforation
• Cataracts or glaucoma
• Secondary infections
• Chronic eye pain

Lifestyle & Prevention

• Protect eyes from injury or trauma
• Manage underlying autoimmune or inflammatory conditions with medical supervision
• Avoid known triggers (e.g., certain medications or environmental factors)
• Use sunglasses to reduce light sensitivity
• Maintain good eye hygiene and avoid rubbing the eyes

When to Seek Professional Help

Seek immediate medical attention if you experience sudden severe eye pain, vision changes, or increased redness. Prompt evaluation is critical to prevent irreversible damage. Follow up with an ophthalmologist if symptoms persist or worsen despite treatment.

Tips for Medical Coders

Document the bilateral nature of the condition and confirm corneal involvement through clinical notes or diagnostic findings. Ensure the code H15.043 is used only when both eyes are affected and corneal involvement is present. Include details about underlying causes or associated systemic conditions if relevant for accurate coding and billing.